4th Annual NGS & Clinical Diagnostics USA Congress

Join Oxford Global for the 4^th Annual Next Generation Sequencing & Clinical Diagnostics USA Congress on 23^rd – 24^th October 2018 in Boston, USA. Discuss the future of sequencing with key innovators from Pharma, Healthcare and Academia! Featuring over 50 presentations and case studies looking at emerging trends in NGS data analysis, clinical diagnostics and biomarker development as well as novel therapeutic applications, this congress will bring together over 200 senior level attendees.

View Agenda https://bit.ly/2JdeZpM  

Pharma – Learn more about NGS in pharmaceutical research and development! Critical case studies and presentations on: whole genome sequencing applications; NGS in clinical trials and NGS in biomarker development.

Healthcare – NGS is revolutionising healthcare, allowing clinicians to take a more personalised approach to care. New for 2018 the congress will be looking at NGS and metagenomics, improved next generation sequencing techniques in liquid biopsy as well NGS in precision medicine.

Academic – Hear about the latest research in the field looking at new technologies and techniques. Critical areas include advances in NGS data analysis, long read vs. short read sequencing and novel therapeutic applications.

Explore streams such as:

·         Exploring Emerging Trends in NGS Data Analysis & NGS Application Strategies

o    Part 2: Future Forward: Where Will Sequencing Take Us?

·         Precision Medicine, Biomarker Development and Clinical Diagnostics

·         The Application of NGS in Different Therapeutic Areas

For further information regarding prices and possible discounts, please contact Angela Fernandez Saez on a.saez@oxfordglobal.co.uk or call +44 (0)1865 248 455.